GlassScriptPhysician profile
Joseph P Hart
NPI 1629006887
$2,297.68
in general payments reported to CMS, 2019-2025
8 companies · $273 in 2025
The $273 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2020: $291 · 2021: $393 · 2022: $260 · 2023: $168 · 2024: $714 · 2025: $273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,155.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $659.25 | 2021-2025 | Endurant Iis |
| W. L. Gore & Associates, INC. | $531.37 | 2020-2024 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Cook Medical LLC | $447.58 | 2020-2024 | Zenith Spiral-Z, Zenith |
| Medtronic Vascular, INC. | $288.41 | 2019-2020 | |
| Atricure, INC. | $158.18 | 2024-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Sirtex Medical INC | $115.99 | 2025 | Lava Les (Liquid Embolic System) |
| Medtronic USA, INC. | $65.49 | 2019 | |
| Artivion, INC. | $31.41 | 2023 | Vascular |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Hart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.